Self-assembling Nanoparticles Based On Amphiphilic Peptides For Drug Delivery Applications Read more about Self-assembling Nanoparticles Based On Amphiphilic Peptides For Drug Delivery Applications Canada3222840Filed on 2023-12-14
GLYCAN-MASKED ENGINEERED OUTER DOMAINS OF HIV-1 GP120 AND THEIR USE Read more about GLYCAN-MASKED ENGINEERED OUTER DOMAINS OF HIV-1 GP120 AND THEIR USE US Application 18/793,025Filed on 2024-08-02
VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES Read more about VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES Australia2024203948Filed on 2024-06-11
METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION Read more about METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION US Patent 11,918,639Filed on 2021-10-11
METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION Read more about METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION US Patent 11,173,201Filed on 2019-10-17
ATTENUATION OF HUMAN RESPIRATORY SYNCYTIAL VIRUS BY GENOME SCALE CODON-PAIR DEOPTIMIZATION Read more about ATTENUATION OF HUMAN RESPIRATORY SYNCYTIAL VIRUS BY GENOME SCALE CODON-PAIR DEOPTIMIZATION US Application 18/756,709Filed on 2024-06-27
NOVEL MALARIA VACCINE COMPRISING AMA1 AND RON2 ANTIGENS Read more about NOVEL MALARIA VACCINE COMPRISING AMA1 AND RON2 ANTIGENS Patent Cooperation TreatyPCT/US2024/035244Filed on 2024-06-24
Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof Read more about Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof Japan2024-091170Filed on 2024-06-05
VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES Read more about VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES US Application 18/758,660Filed on 2024-06-28